Skip to main content

Hematopoietic and Lymphoid Cell Neoplasm clinical trials at UCSD
1 in progress, 1 open to new patients

  • Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer

    open to eligible people ages 18 years and up

    This pilot phase I trial studies the side effects of atezolizumab in treating patients with cancer following adoptive cell transfer. Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread.

    La Jolla, California and other locations